|
RxMD is a therapeutics company committed to developing and establishing clinical proof of concept for early stage drug candidates. Our collaborative business approach allows partners to access RxMD's clinical development capabilities and expertise. RxMD eschews traditional 'fee for service' relationships, operating instead under success-based outcome agreements. RxMD primarily seeks emerging market rights in our collaborations. RxMD has partnered to successfully develop multiple commercialized products for leading global biopharmaceutical companies. |
||||||||||||
|
||||||||||||